Related references
Note: Only part of the references are listed.Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
Connecting With Patients-The Missing Links
Lisa Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
Huilan Zhang et al.
ANNALS OF INTERNAL MEDICINE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Pulmonary Embolism in Patients With COVID-19 Awareness of an Increased Prevalence
Julien Poissy et al.
CIRCULATION (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
ECMO for ARDS due to COVID-19
Silvio A. Namendys-Silva
HEART & LUNG (2020)
The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
Spyridon G. Deftereos et al.
HELLENIC JOURNAL OF CARDIOLOGY (2020)
SARS-CoV-2: a storm is raging
Savannah F. Pedersen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
Murray Esler et al.
JOURNAL OF HYPERTENSION (2020)
Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected with Pulmonary CT Angiography
Franck Grillet et al.
RADIOLOGY (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
COVID-19, ECMO, and lymphopenia: a word of caution
Brandon Michael Henry
LANCET RESPIRATORY MEDICINE (2020)
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lei Fang et al.
LANCET RESPIRATORY MEDICINE (2020)
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou et al.
CELL DISCOVERY (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
Zhe Zhu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients
Chaofu Wang et al.
EBIOMEDICINE (2020)
Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports
Brandon Michael Henry et al.
JOURNAL OF CRITICAL CARE (2020)
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
Henning Ulrich et al.
STEM CELL REVIEWS AND REPORTS (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
SURFACTANT PROTEIN D DAMPENS LUNG INJURY BY SUPPRESSING NLRP3 INFLAMMASOME ACTIVATION AND NF-kappa B SIGNALING IN ACUTE PANCREATITIS
Jia Yu et al.
SHOCK (2019)
Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC
Kam-Leung Siu et al.
FASEB JOURNAL (2019)
Safety and efficacy of beta-blockers to improve oxygenation in patients on veno-venous ECMO
Jeroen J. H. Bunge et al.
JOURNAL OF CRITICAL CARE (2019)
The association between premorbid beta blocker exposure and mortality in sepsis-a systematic review
Kaiquan Tan et al.
CRITICAL CARE (2019)
beta-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease - A Danish Nationwide Study of 1.3 Million Individuals
Anne Orholm Nielsen et al.
ECLINICALMEDICINE (2019)
Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
Wei-Ting Wong et al.
FRONTIERS IN IMMUNOLOGY (2018)
Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma
Dong Jiang et al.
CELL DEATH & DISEASE (2018)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
INTENSIVE CARE MEDICINE (2017)
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis
Roeland F. Stolk et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Acute respiratory distress syndrome
Rob Mac Sweeney et al.
LANCET (2016)
Inhalation of a Short-Acting β2-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy Subjects
Mais Ali-Saleh et al.
PLOS ONE (2016)
NOREPINEPHRINE: NOT TOO MUCH, TOO LONG
Claude Martin et al.
SHOCK (2015)
β-blockers in critically ill patients: from physiology to clinical evidence
Silvia Coppola et al.
CRITICAL CARE (2015)
β2-Adrenoceptor Involved in Smoking-Induced Airway Mucus Hypersecretion through β-Arrestin-Dependent Signaling
Yujiao Zhou et al.
PLOS ONE (2014)
Propranolol induces apoptosis of human umbilical vein endothelial cells through downregulation of CD147
W. Xie et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
ß-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCd/p38 MAPK signalling in neonatal mouse cardiac fibroblasts
Chao Chen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Contribution of alpha- and beta-Adrenergic Mechanisms to the Development of Pulmonary Edema
Beate Rassler
SCIENTIFICA (2012)
ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease
Luiza A. Rabelo et al.
HYPERTENSION RESEARCH (2011)
Effects of an Inhaled β2-Agonist on Cardiovascular Function and Sympathetic Activity in Healthy Subjects
Eric M. Snyder et al.
PHARMACOTHERAPY (2011)
Effect of oral beta-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL II-ICU study
Markus Noveanu et al.
CRITICAL CARE (2010)
Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis
Kevin C. Doerschug et al.
CRITICAL CARE (2010)
Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-κB
Xue Zhang et al.
VIROLOGY (2007)
Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis
MR Hoppener et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Effect of propranolol on cardiac cytokine expression after myocardial infarction in rats
A Deten et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop
Y Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Effect of beta blockers on expression of interleukin-6 and C-reactive protein in patients with unstable angina pectoris
YC Doo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo
R von Känel et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
Share Paper
